Postexposure Prophylaxis of Breastfeeding HIV-Exposed Infants With Antiretroviral Drugs to Age 14 Weeks: Updated Efficacy Results of the PEPI-Malawi Trial

Taha E. Taha(Blantyre Institute for Community Ophthalmology), Allan W. Taylor, Donald R. Hoover(Rutgers, The State University of New Jersey), Michael C. Thigpen(Walter Reed Army Institute of Research), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Linda Mipando(Johns Hopkins University), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Li Q(Sichuan University), Kondwani Nkanaunena(Johns Hopkins University), Mary Glenn Fowler(Johns Hopkins University)
JAIDS Journal of Acquired Immune Deficiency Syndromes
March 19, 2011
10.1097/qai.0b013e318217877a
Cited by 36

Related Papers

Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
|PsycEXTRA Dataset|2006|3k
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
|BMJ|2020|2.4k
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
|New England Journal of Medicine|2012|2k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k